January 13, 2023

The American Board of Pathology Announces the Appointment of May Chan, MD to the Test Development and Advisory Committee for Dermatopathology

The Department of Pathology offers its congratulations to Dr. May Chan, Professor of Dermatopathology, on her appointment to the American Board of Pathology's Test Development and Advisory Committee beginning in 2023. "As an established subject matter expert in dermatopathology, the contributions of Dr. Chan will be highly valued," commented Bonnie Woodworth, ABP Communications Director. Chan, who also serves as the Program Director for the Dermatopathology Fellowship Program, commented, "With this appointment, I’ll be joining seven esteemed dermatopathologists in designing and writing questions for the dermpath board exam and for the dermpath portion of the anatomic pathology board exam.

All News General News
December 22, 2022

Peek Inside a Bank Full of Priceless Gifts

Blood banks need a constant supply of deposits to meet the needs of patients with cancer, traumatic injuries, failing organs, blood diseases, and more. Deep inside the main University of Michigan hospital lies a gleaming new bank, devoted to handling priceless treasure and storing it safely.

All News General News
December 6, 2022

Rogel Researchers Receive $4M Through Prostate Cancer Foundations Inaugural TACTICAL Awards Program

The University of Michigan Rogel Cancer Center researchers received one of the Prostate Cancer Foundation’s four inaugural Class of 2022 TACTICAL (Therapy Acceleration To Intercept Cancer Lethality) Award. This $30 million program will support cross-disciplinary pioneering research toward the goal of developing 21st Century therapies for the most life-threatening form of prostate cancer.

All News General News
August 17, 2022

A New Cooperation between EZH2 and p38 Proteins Enhances Metastasis in Triple Negative Breast Cancer

The Celina Kleer lab at the University of Michigan Department of Pathology and Rogel Cancer Center has found a new mechanism that fuels metastasis in triple negative breast cancers. In their new study they show that EZH2, a master regulator of cell type identity, known to function through methylation of histones, has a new, unexpected function in aggressive breast cancers. By adding methyl groups to the p38 protein, EZH2 enhances the ability of breast cancer cells to spread to other tissue throughout the body, a process known as metastasis.

All News Scientific and Clinical Research